Additionally, for hydroxychloroquine, a recent study pointed out that hydroxychloroquine could lead to unwanted QT interval prolongation by blocking the KCNH2-encoded hERG/Kv11.1 potassium channel, thereby increasing the risk of drug-induced torsade de pointes and sudden cardiac death (83). The gene discussed is KCNA3; the disease is torsades de pointes.